Since 2017, Dr. Yaker has offered patients a compounded topical version of Finasteride combined with pharmaceutical grade Minoxidil. HÄR LAB NO. 2 contains the same ingredients found in HÄR LAB NO. 1 (pharmaceutical grade Minoxidil only), plus the DHT-blocking medication, Finasteride. 

With topical Finasteride gaining popularity due to proven results with minimal risks of side effects, more men are choosing this treatment option as opposed to oral Finasteride. In addition, men who are concerned with or who have had sexual side effects with oral Finasteride have been able to safely switch over to HÄR LAB NO. 2. Female candidates include women who are not of child-bearing age or who are on birth control, or who cannot get pregnant.